首页> 外文期刊>The Lancet >Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomised controlled trial.
【24h】

Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomised controlled trial.

机译:溶栓与局部缺血引导的保守治疗24小时内ST抬高ST段(GRACIA-1)的常规侵入性策略:一项随机对照试验。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: In patients with ST-segment elevated myocardial infarction (STEMI), early post-thrombolysis routine angioplasty has been discouraged because of its association with high incidence of events. The GRACIA-1 trial was designed to reassess the benefits of an early post-thrombolysis interventional approach in the era of stents and new antiplatelet agents. METHODS: 500 patients with thrombolysed STEMI (with recombinant tissue plasminogen activator) were randomly assigned to angiography and intervention if indicated within 24 h of thrombolysis, or to an ischaemia-guided conservative approach. The primary endpoint was the combined rate of death, reinfarction, or revascularisation at 12 months. Analysis was by intention to treat. FINDINGS: Invasive treatment included stenting of the culprit artery in 80% (199 of 248) patients, bypass surgery in six (2%), non-culprit artery stenting in three, and no intervention in 40 (16%). Predischarge revascularisation was needed in 51 of 252 patients in the conservative group. By comparison with patients receiving conservative treatment, by 1 year, patients in the invasive group had lower frequency of primary endpoint (23 [9%] vs 51 [21%], risk ratio 0.44 [95% CI 0.28-0.70], p=0.0008), and they tended to have reduced rate of death or reinfarction (7% vs 12%, 0.59 [0.33-1.05], p=0.07). Index time in hospital was shorter in the invasive group, with no differences in major bleeding or vascular complications. At 30 days both groups had a similar incidence of cardiac events. In-hospital incidence of revascularisation induced by spontaneous recurrence of ischaemia was higher in patients in the conservative group than in those in the invasive group. INTERPRETATION: In patients with STEMI, early post-thrombolysis catheterisation and appropriate intervention is safe and might be preferable to a conservative strategy since it reduces the need for unplanned in-hospital revascularisation, and improves 1-year clinical outcome.
机译:背景:在ST段抬高型心肌梗死(STEMI)患者中,由于其与事件高发相关,因此不鼓励早期溶栓后常规血管成形术。 GRACIA-1试验旨在重新评估支架和新抗血小板药物时代溶栓后早期介入治疗的益处。方法:如果溶栓后24小时内有适应症,则随机分配500例溶栓性STEMI患者(带有重组组织纤溶酶原激活剂)进行血管造影和介入治疗,或采用局部缺血指导的保守治疗。主要终点是12个月时的死亡,再梗塞或血运重建的总发生率。分析是按意向进行的。结果:有创治疗包括:在80%(248名患者中的199名)患者中对罪犯动脉进行支架置入,对6例(2%)进行旁路手术,对3名非罪犯动脉支架置入和40例(16%)不进行干预。保守组252例患者中有51例需要进行出院前血运重建。与接受保守治疗的患者相比,到1年时,侵入组患者的主要终点发生率较低(23 [9%] vs 51 [21%],风险比0.44 [95%CI 0.28-0.70],p = 0.0008),他们的死亡率或再梗塞率往往降低(7%对12%,0.59 [0.33-1.05],p = 0.07)。浸润组的住院时间较短,主要出血或血管并发症无差异。两组在第30天的心脏事件发生率相似。保守组患者因局部缺血再发引起的血运重建的院内发生率高于侵入性组。解释:在STEMI患者中,溶栓后早期插管和适当的干预是安全的,并且比保守的策略更可取,因为它减少了计划外的院内血运重建的需要,并改善了1年的临床结局。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号